The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients
O. Zill, K. Banks, S. Fairclough, S. Mortimer, J. Vowles, R. Mokhtari, D. R. Gandara, P. C. Mack, J. Odegaard, R. Nagy, A. Baca, H. Eltoukhy, D. Chudova, R. Lanman, A. Talasaz
This study analyzes cfDNA from 21,807 cancer patients to identify actionable genomic alterations and their relationship to treatment and tumor heterogeneity.
bioRxiv · Dec 12, 2017Cancer Biology